Literature DB >> 23618817

Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.

Jiwen Wang1, Jia Gao, Yingjie Li, Xiaoxia Zhao, Wei Gao, Li Peng, Dangui Yan, Lisheng Liu, Dongmei Li, Lili Wei, Jun Qi, Changchun Zhou.   

Abstract

Accumulating evidences indicate that the functional FAS-1377G>A, -670A>G and FASL-844T>C polymorphisms affect the risk of several kinds of cancers. However, their roles in the development of larynx and hypopharynx squamous cell carcinoma (SCC) were still unknown in the Chinese. In the current study, we examined whether these functional genetic variants were associated with the risk of larynx and hypopharynx squamous SCC in a Han Chinese population. The FAS and FASL polymorphisms were genotyped in 300 patients with laryngeal and hypopharyngeal SCC and 300 control subjects by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Logistic regression analysis revealed that subjects carrying the FASL-844CT or TT genotype had a significantly decreased risk of developing laryngeal and hypopharyngeal SCC [odds ratio (OR)=0.69; 95% confidence interval (CI)=0.51-0.93; P=0.016; or, OR=0.41; 95% CI=0.20-0.86; P=0.009] compared with those carrying the CC genotype. Joint gene-smoking and gene-drinking effects were also observed, with the OR of CC genotype for smokers or drinkers were 5.15 (95%CI=3.24-8.97) or 12.52 (95%CI=7.31-22.47), respectively. Therefore, the FASL-844T>C polymorphism is associated with genetic susceptibility of developing laryngeal and hypopharyngeal SCC in a Han Chinese population.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23618817     DOI: 10.1016/j.gene.2013.04.034

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects.

Authors:  W Chen; Z Y Wang; F L Xu; K M Wu; Y Zhang; L Xu; Q P Wang
Journal:  Tumour Biol       Date:  2013-11-06

2.  Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.

Authors:  Tao Liu; Li Zuo; Lin Li; Lei Yin; Kai Liang; Hongyuan Yu; Hui Ren; Wen Zhou; Hongwei Jing; Yang Liu; Chuize Kong
Journal:  Tumour Biol       Date:  2014-08-02

3.  Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking.

Authors:  Xiaoyu Li; Jing Xu; Xinxin Yang; Yungang Wu; Baohua Cheng; Dongfeng Chen; Bo Bai
Journal:  Tumour Biol       Date:  2014-02-22

4.  Association of C722T polymorphism in XRCC3 gene with larynx cancer: a meta-analysis.

Authors:  Dong Li; Hui-Hua You; Yuan-Jing Jia; Jian-Dong Guo; Huan-Le Du
Journal:  Tumour Biol       Date:  2014-02-13

5.  CD95 rs1800682A/G variant and tumor risk in Asians: evidence from a meta-analysis of 36 case-control studies containing 22,438 samples.

Authors:  Cheng Jin; Xiaomin Wu; Yuanlong Gu; Fenglai Yuan; Qinghai Ye; Feng Dai; Lijie Zhu; Yuanyuan Mi
Journal:  Med Sci Monit       Date:  2015-02-27

6.  FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.

Authors:  Lei Xu; Xin Zhou; Feng Jiang; Man-Tang Qiu; Zhi Zhang; Rong Yin; Lin Xu
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

7.  Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95.

Authors:  Anindita Das; David Durrant; Clint Mitchell; Paul Dent; Surinder K Batra; Rakesh C Kukreja
Journal:  Oncotarget       Date:  2016-01-26

8.  Fas-670A>G polymorphism is not associated with an increased risk of acute myeloid leukemia development.

Authors:  Ying Huang; Donghong Deng; Hongying Li; Qiang Xiao; Lulu Huang; Bing Zhang; Fanghui Ye; Bingbing Ye; Zengnan Mo; Xiaobo Yang; Zhenfang Liu
Journal:  Biomed Rep       Date:  2015-12-31

9.  Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.

Authors:  Yan Sun; Wenbin Yu; Erich M Sturgis; Wei Peng; Dapeng Lei; Qingyi Wei; Xicheng Song; Guojun Li
Journal:  BMC Cancer       Date:  2016-02-08       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.